Lancaster Eric

Lancaster Eric, a Pennsylvania-based sole proprietorship, provides independent medical analysis, case review, expert medical opinions, and expert witness testimony for the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP) administered by the Health Resources and Services Administration, exclusively as a prime contractor (100% of recent awards) on a full-and-open, non-set-aside basis, though Lancaster Eric also competes for and holds awards under total small business set-asides.

The vendor operates from Wynnewood, Pennsylvania, and is classified under NAICS 621111 (Offices of Physicians except Mental Health Specialists) and PSC Support—Professional: Expert Witness. Lancaster Eric concentrates almost entirely on VICP and CICP medical adjudication work; the firm has no subcontracting activity and no secondary customer base outside federal vaccine injury compensation programs.

Lancaster Eric's customer concentration is extreme and non-diversified. The Department of Health and Human Services Health Resources and Services Administration Headquarters accounts for 132 of 138 awards (95.7% of awards) and $22.4 million of $22.5 million combined potential value (99.6%). The Department of Justice Civil Division places 6 awards worth $32 thousand. Recent representative work includes a $37,500 BPA call from HRSA for medical case review services under the new $7.5 million VICP/CICP BPA (HSB114 C 7531) awarded May 18, 2026, a $24,375 small-business-set-aside BPA call from HRSA for VICP medical expert services awarded February 12, 2026, multiple smaller calls ($2,250 to $15,000) for individual VICP case reviews under prior HRSA BPAs, and time-and-materials purchase orders from DOJ Civil Division for expert witness services ranging from $1,875 to $13,106.

Lancaster Eric holds four active parent BPAs, all with HRSA: the new HSB114 C 7531 ($7.5 million ceiling, awarded May 18, 2026, running through May 17, 2031) explicitly covers both VICP and CICP medical expert services; BPA 75R60221A00018 ($249,999 ceiling, originally awarded April 21, 2021, extended through April 20, 2026) anchors 50 task orders worth $388 thousand; BPA HHSH250201400098B carries 58 task orders worth $193 thousand; and BPA 75R60219A00045 carries 19 task orders worth $55 thousand. Task orders under these vehicles are structured as firm fixed-price calls for individual VICP or CICP cases, ranging from $750 to $15,000 per order, with hourly rates disclosed in some calls at $375 per hour.

Activity peaked in 2022–2024 (12 to 14 awards per year) and has declined sharply—seven awards in 2025 and four through August 2026. Six awards (combined potential value $111 thousand) reach completion within the next twenty-four months, representing modest recompete exposure relative to the vendor's overall contract ceiling. Obligated spending stands at $706 thousand against $22.5 million in combined potential value, indicating the BPA vehicles carry substantial unused authorization or that task orders are small relative to the ceiling.

The vendor's footprint reflects a highly specialized, single-customer, single-mission business model. Lancaster Eric operates as a medical expert services provider exclusively for federal vaccine injury compensation claim adjudication, with no diversification into other medical consulting domains, other federal agencies, or commercial work. This concentration creates both structural advantage (deep domain expertise, long-standing relationship with HRSA) and structural risk (customer and program concentration, recompete exposure if HRSA consolidates vendor capacity or shifts procurement approach).